: CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial 1 de novembro de 2020 by r4ibom in Uncategorized German biotech CureVac said advanced clinical trials are on track to launch by the end of 2020. Compartilhe isso: Clique para compartilhar no X(abre em nova janela) 18+ Clique para compartilhar no Facebook(abre em nova janela) Facebook 1 de novembro de 2020
